Q-Line Biotech IPO Allotment Status: Check Latest GMP, Steps to Verify Status
The allotment for the ₹214.48 crore Q-Line Biotech IPO is anticipated to be finalised today, May 26, 2026. Investors can check their status on official platforms, such as the NSE website and the IPO registrar's portal, Purva Sharegistry Private Limited.
Procedure to Check Q-Line Biotech IPO Allotment Status Online On NSE
- Visit the NSE’s IPO allotment verification status page here.
- Select “ Equity & SME IPO bid details”.
- In Select Symbol, select “QLINE”
- Enter your PAN No. and Application No.
- Click “Submit”.
Procedure to Check Q-Line Biotech IPO Allotment Status on Purva Sharegistry Private Limited (Registrar to the issue)
- Visit the Purva Sharegistry’s IPO allotment status page here.
- In Select Company, select “Q-Line Biotech”.
- Enter any of the following details.
- App. No.
- PAN Number Demat Acct
- Click “Search”.
Q-Line Biotech IPO - Issue Details
Issue Type: 100% Book Building IPO
Total Issue size: ₹214.48 crore
Fresh Issue: ₹214.48 crore (0.63 crore equity shares)
Price Band: ₹326 to ₹343 per share
Face Value: ₹10 per share
Lot Size: 400 Shares
Minimum Investment (Individual Investor): ₹2,74,400 (800 shares)
Book Running Lead Managers: HEM Securities Limited and Share India Capital Services Private Limited
Registrar: Purva Sharegistry Private Limited
Listing: NSE SME
Q-Line Biotech IPO Overall Subscription Status
[May 25, 2026, 6:30 PM]
|
Category |
Subscription (Times) |
|
Qualified Institutional Buyers (QIBs) |
123.94 |
|
Non-Institutional Investors (NIIs) |
145.98 |
|
Individual Investors |
71.44 |
|
Total |
102.42 |
Q-Line Biotech IPO GMP Today
According to media reports, the Grey Market Premium (GMP) of Q-Line Biotech IPO is ₹101 per share today.
Utilisation of Q-Line Biotech IPO Proceeds
The Company will utilise the net proceeds from the Fresh Issue towards the following purposes:
- To meet the working capital requirements of the Company
- Repayment or certain borrowing availed by the Company, in part or in full.
- General Corporate Purposes.
Check out newly listed IPOs on BSE and NSE.
Q-Line Biotech Limited Overview
Q-Line Biotech Limited is a Lucknow-based in vitro diagnostics (IVD) company engaged in the development, manufacturing, and marketing of a diverse range of reagents, consumables, and diagnostic equipment to meet healthcare needs. Founded in 2013, the company serves diagnostic service providers, hospitals, and medical colleges across 26 states and union territories in India, primarily through a B2B model. Its core business spans five segments: Clinical Chemistry, Haematology, Immunodiagnostics, Molecular Diagnostics, and POC Devices & Rapids.
Q-Line Biotech has demonstrated consistent revenue growth, with consolidated revenue from operations rising from ₹182.7 crore in FY23 to ₹313.8 crore in FY25. PAT stood at ₹28.1 crore in FY25, compared to ₹34.4 crore in FY24.
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here.